Odyssean »

Advansix shares owned by Odyssean

Quarter-by-quarter ownership of Advansix (ASIX) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Advansix

Tip: Access up to 7 years of quarterly data

All positions including Advansix held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Advansix by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $240k 12k 19.88

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Advansix

BlackRock
CastleKnight Management
Dimensional Fund Advisors
American Century Companies
Aegis Financial Corporation
Vanguard Capital Management
Alliancebernstein
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Geode Capital Management
AQR Capital Management
Two Sigma Investments
FMR
State Street Corporation
Goldman Sachs Group

View all funds holding Advansix